Lilly leaders discuss Alzheimer’s disease impact on local communities
The company hopes that these regional Community Conversations events will encourage better preparedness plans in the U.S.
Experts estimate that Alzheimer’s disease prevalence will triple by the year 2050. Because of this, there is a major need for more awareness of how Alzheimer’s socially and economically affects communities, families and health systems.
"With the prevalence of Alzheimer's in Indiana slated to increase by 18 percent by 2025, the U.S. Conference of Mayors seemed like a critical opportunity to highlight Alzheimer's services and discuss the broader impact this disease has on our communities," Indianapolis Mayor Joe Hogsett said. "Through the Community Conversations program, I'm hopeful we'll not only continue to educate and activate residents, but share insights with other cities to encourage similar action across the country."
The company’s health experts have broadened its Community Conversations on Alzheimer’s events to include a panel discussion with the U.S. Conference of Mayors. The meeting is held in Indianapolis, Indiana.
"For more than a quarter of a century, Lilly has been continuously working toward identifying meaningful solutions to help those living with Alzheimer's disease and their families," Phyllis Ferrell, vice president and head of Lilly's Global Alzheimer's Disease Platform Team, said. "We're hopeful that, by helping organizations work together to identify the issues and challenges within their communities that may impede detection and diagnosis, we'll be able to shift perceptions of the disease as a whole."
Organizations in this story
Eli Lilly and Company 1555 S Harding St Indianapolis, IN - 46221